Studied regenerative or supportive role in collagen / skin matrix — see peptide root ledger.
Target condition: metformin. Body system: Metabolic tool; B12/mitochondrial concerns at chronic use — context dependent..
Logic chain
ghk-cu studied regenerative or supportive role in collagen / skin matrix — see peptide root ledger..
metformin involves metabolic tool; b12/mitochondrial concerns at chronic use — context dependent. dysfunction.
If ghk-cu reaches the affected tissue, it may shift the repair/breakdown balance.
This chain is under investigation.
Parent peptide claims relevant here
Plasma GHK levels measure approximately 200 ng/mL at age 20 and decline to approximately 80 ng/mL by age 60.
In human dermal fibroblast cultures, GHK-Cu at nanomolar concentrations increases synthesis of collagen types I, III, and IV as well as elastin and glycosaminoglycans.
Placebo-controlled topical application studies in women around age 50 reported improved skin quality parameters and increased collagen deposition in skin biopsies.
A registered Phase 2 randomized double-blind trial (NCT07437586) is evaluating topical GHK-Cu gel versus vehicle for acute skin wound re-epithelialization in healthy adults.
2018 review on GHK-Cu regenerative actions based on gene data, covering wound healing, skin regeneration, anti-inflammatory effects.
Evidence tier
Evidence status unclear — research ongoing.
What we do not know
Whether ghk-cu reaches metformin tissue at functional concentrations
Optimal dosing, route, and duration for this target
Interaction with standard-of-care treatments for metformin
Long-term safety profile in this population
Safety note
All peptide use for metformin is research-context only. Not medical advice. Consult a physician before any experimental compound.
the whole object this page is drawn from, as JSON
{
"schema":"https://miscsubjects.com/schemas/jarticle.json",
"status":"published",
"slug":"ghk-cu-metformin",
"title":"GHK-Cu × Metformin",
"kind":"standard",
"summary":"metformin represents tissue breakdown exceeding repair capacity. Most interventions manage symptoms. This article examines whether ghk-cu mechanisms address underlying repair deficits. Studied regenerative or supportive role in collagen /",
"created":"2026-08-08T04:22:52.377Z",
"body": [
"## Regeneration vs degeneration — where this fits\n\nmetformin represents tissue breakdown exceeding repair capacity. Most interventions manage symptoms. This article examines whether ghk-cu mechanisms address underlying repair deficits.\n\n## What is known\n\nStudied regenerative or supportive role in collagen / skin matrix — see peptide root ledger.\n\nTarget condition: metformin.\nBody system: Metabolic tool; B12/mitochondrial concerns at chronic use — context dependent..\n\n## Logic chain\n\n1. ghk-cu studied regenerative or supportive role in collagen / skin matrix — see peptide root ledger..\n2. metformin involves metabolic tool; b12/mitochondrial concerns at chronic use — context dependent. dysfunction.\n3. If ghk-cu reaches the affected tissue, it may shift the repair/breakdown balance.\n4. This chain is under investigation.\n\n## Parent peptide claims relevant here\n\n- Plasma GHK levels measure approximately 200 ng/mL at age 20 and decline to approximately 80 ng/mL by age 60.\n- In human dermal fibroblast cultures, GHK-Cu at nanomolar concentrations increases synthesis of collagen types I, III, and IV as well as elastin and glycosaminoglycans.\n- Placebo-controlled topical application studies in women around age 50 reported improved skin quality parameters and increased collagen deposition in skin biopsies.\n- A registered Phase 2 randomized double-blind trial (NCT07437586) is evaluating topical GHK-Cu gel versus vehicle for acute skin wound re-epithelialization in healthy adults.\n- 2018 review on GHK-Cu regenerative actions based on gene data, covering wound healing, skin regeneration, anti-inflammatory effects.\n\n## Evidence tier\n\nEvidence status unclear — research ongoing.\n\n## What we do not know\n\n- Whether ghk-cu reaches metformin tissue at functional concentrations\n- Optimal dosing, route, and duration for this target\n- Interaction with standard-of-care treatments for metformin\n- Long-term safety profile in this population\n\n## Safety note\n\nAll peptide use for metformin is research-context only. Not medical advice. Consult a physician before any experimental compound."
],
"facts": {
"converted_from":"markdown",
"original_updated":"2026-07-17T02:39:23.068Z",
"register":"standard",
"category":null
},
"model":"grok/grok-4.3",
"tags": [
"peptide"
],
"type":"article",
"updated":"2026-10-08T11:31:15.697Z",
"version":1,
"hash":"a89b04c2d6298a31b3230362cfeed38dc25f378abb735385a1f8c8469ce3c141",
"styling": {
"scope":"shared",
"how":"no value on the page is set by hand: each comes from this theme, and each theme value becomes the CSS variable named beside it. PATCH https://miscsubjects.com/api/jarticles/theme changes them.",
"widget_style": {
"what":"every widget may carry style: {…}; these are the only keys it reads",
"rotate":"degrees, a number",
"offset_x":"pixels, a number",
"offset_y":"pixels, a number",
"pulse":"true to pulse"
},
"theme": {
"color": {
"page_bg":"#f5f5f7",
"sheet_bg":"#ffffff",
"ink":"#1d1d1f",
"soft":"#424245",
"muted":"#6e6e73",
"dim":"#86868b",
"line":"#d2d2d7",
"accent":"#0071e3",
"accent_soft":"rgba(0,113,227,0.08)",
"link":"#0066cc",
"selection":"rgba(0,113,227,0.18)",
"widget_bg":"#f5f5f7",
"widget_border":"#d2d2d7",
"card_bg":"#ffffff",
"code_bg":"#f5f5f7",
"json_bg":"#161b19",
"json_ink":"#e6e1d4",
"json_key":"#7fd3c3",
"json_string":"#e9c46a",
"json_number":"#f4a261",
"json_bool":"#c792ea",
"json_null":"#928d7e",
"json_punct":"#6b6759",
"json_bar":"#0e1512",
"kind_badge_bg":"#0e6e60",
"kind_badge_ink":"#ffffff"
},
"color_dark": {
"page_bg":"#000000",
"sheet_bg":"#1d1d1f",
"ink":"#f5f5f7",
"soft":"#d2d2d7",
"muted":"#a1a1a6",
"dim":"#86868b",
"line":"#424245",
"accent":"#2997ff",
"accent_soft":"rgba(41,151,255,0.12)",
"link":"#2997ff",
"selection":"rgba(41,151,255,0.25)",
"widget_bg":"#2c2c2e",
"widget_border":"#424245",
"card_bg":"#1d1d1f",
"code_bg":"#2c2c2e",
"json_bg":"#0a0d0c",
"json_ink":"#e6e1d4",
"json_key":"#7fd3c3",
"json_string":"#e9c46a",
"json_number":"#f4a261",
"json_bool":"#c792ea",
"json_null":"#757062",
"json_punct":"#5d665f",
"json_bar":"#060807",
"kind_badge_bg":"#4fc1ab",
"kind_badge_ink":"#0b0f0d"
},
"font": {
"display":"-apple-system,BlinkMacSystemFont,\"SF Pro Display\",\"SF Pro Text\",\"Helvetica Neue\",Helvetica,Arial,sans-serif",
"body":"-apple-system,BlinkMacSystemFont,\"SF Pro Display\",\"SF Pro Text\",\"Helvetica Neue\",Helvetica,Arial,sans-serif",
"mono":"ui-monospace,SFMono-Regular,\"SF Mono\",Menlo,Consolas,monospace",
"google_fonts":""
},
"size": {
"body":"17px",
"small":"17px",
"eye":"17px",
"lead":"17px",
"h1":"52px",
"h2":"34px",
"h3":"22px",
"byline":"17px",
"h1_measure":"none",
"code":"17px",
"json":"17px",
"widget_title":"17px"
},
"leading": {
"body":"1.7",
"head":"1.18",
"lead":"1.5",
"json":"1.6"
},
"weight": {
"display":"700",
"head":"700",
"body":"400",
"strong":"700",
"eye":"700"
},
"tracking": {
"eye":"0.14em",
"display":"-0.03em",
"body":"-0.006em",
"badge":"0.08em"
},
"layout": {
"sheet_width":"1000px",
"text_width":"880px",
"gutter":"16px",
"sheet_padding":"56px 64px 64px",
"sheet_padding_mobile":"24px 18px 40px",
"sheet_margin":"28px auto 72px",
"block_gap":"1.15em",
"widget_gap":"28px",
"grid_gap":"14px"
},
"border": {
"sheet":"0px solid",
"sheet_radius":"30px",
"widget":"1px solid",
"widget_radius":"24px",
"card_radius":"24px",
"badge_radius":"999px",
"rule":"1px solid",
"code_radius":"18px",
"accent_bar":"3px"
},
"shadow": {
"sheet":"0 1px 1px rgba(0,0,0,.02),0 6px 26px rgba(0,0,0,.05)",
"widget":"none",
"card_hover":"0 10px 28px -16px rgba(28,27,23,0.35)"
},
"motion": {
"hover":"160ms ease"
}
}
},
"page":"https://miscsubjects.com/a/ghk-cu-metformin",
"json":"https://miscsubjects.com/a/ghk-cu-metformin.json",
"markdown":"https://miscsubjects.com/a/ghk-cu-metformin.md",
"theme":"https://miscsubjects.com/article-theme.json",
"calls": [
{
"what":"this article as a page (no key)",
"method":"GET",
"url":"https://miscsubjects.com/a/ghk-cu-metformin",
"headers": {}
},
{
"what":"this article as its object (no key)",
"method":"GET",
"url":"https://miscsubjects.com/a/ghk-cu-metformin.json",
"headers": {}
},
{
"what":"this article as Markdown (no key)",
"method":"GET",
"url":"https://miscsubjects.com/a/ghk-cu-metformin.md",
"headers": {}
},
{
"what":"the object with its hash, drafts too",
"method":"GET",
"url":"https://miscsubjects.com/api/jarticles/ghk-cu-metformin",
"headers": {
"x-sheets-key":"$(cat /Users/cyrusmassoumi/.misc-sheets-key)"
}
},
{
"what":"one piece and that piece’s hash",
"method":"GET",
"url":"https://miscsubjects.com/api/jarticles/ghk-cu-metformin/at?path=facts",
"headers": {
"x-sheets-key":"$(cat /Users/cyrusmassoumi/.misc-sheets-key)"
}
},
{
"what":"grep: every key or value that matches, with the path to change it",
"method":"GET",
"url":"https://miscsubjects.com/api/jarticles/ghk-cu-metformin/grep?q=owner",
"headers": {
"x-sheets-key":"$(cat /Users/cyrusmassoumi/.misc-sheets-key)"
}
},
{
"what":"change pieces (set, merge, delete, append, insert, move); if-match is the hash",
"method":"PATCH",
"url":"https://miscsubjects.com/api/jarticles/ghk-cu-metformin",
"headers": {
"x-sheets-key":"$(cat /Users/cyrusmassoumi/.misc-sheets-key)",
"content-type":"application/json",
"if-match":"<hash from the read>"
},
"body": {
"ops": [
{
"op":"set",
"path":"facts.example",
"value":1
}
]
}
},
{
"what":"replace the whole object",
"method":"PUT",
"url":"https://miscsubjects.com/api/jarticles/ghk-cu-metformin",
"headers": {
"x-sheets-key":"$(cat /Users/cyrusmassoumi/.misc-sheets-key)",
"content-type":"application/json",
"if-match":"<hash>"
},
"body": {
"slug":"ghk-cu-metformin",
"title":"…"
}
},
{
"what":"fetch every source, hash what came back and check the quote is in it",
"method":"POST",
"url":"https://miscsubjects.com/api/jarticles/ghk-cu-metformin/verify",
"headers": {
"x-sheets-key":"$(cat /Users/cyrusmassoumi/.misc-sheets-key)",
"content-type":"application/json"
},
"body": {}
},
{
"what":"an Obsidian-style command",
"method":"POST",
"url":"https://miscsubjects.com/api/jarticles/cli",
"headers": {
"x-sheets-key":"$(cat /Users/cyrusmassoumi/.misc-sheets-key)",
"content-type":"application/json"
},
"body": {
"command":"backlinks",
"file":"ghk-cu-metformin"
}
}
]
}